TRACON Pharmaceuticals (TCON)
(Delayed Data from OTC)
$0.66 USD
+0.03 (4.78%)
Updated Jul 25, 2024 02:23 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
TCON 0.66 +0.03(4.78%)
Will TCON be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for TCON based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for TCON
Tracon (TCON) Moves to Buy: Rationale Behind the Upgrade
TCON: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for TCON
TRACON Pharmaceuticals Announces Executive Officer Resignation
12 Health Care Stocks Moving In Monday's Pre-Market Session
Biotech Alert: Searches spiking for these stocks today
Why Broadcom Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
Why Streamline Health Solutions Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session